International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Sotalol 5-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2011 - Volume 15, Number 5
View All Articles in Issue

Page(s): 425

Download in electronic PDF format for $75

Abstract: A formulation for preparing Sotalol 5-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, nonselective beta blocker, sotalol, ventricular arrhythmia, supraventricular tachycardia

Related Categories: FORMULATIONS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Sotalol 5-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 425
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Sotalol Hydrochloride 5-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 144
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Sidhom Madiha B, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L	Sep/Oct 2005 Pg. 402-406
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Hagan John C III, Everett Eric, Chamberlain Tyler	May/Jun 2020 Pg. 194-197
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Riepl Mike	Sep/Oct 2022 Pg. 364-368
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE	Jul/Aug 2016 Pg. 328-332
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Zur Eyal	Nov/Dec 2011 Pg. 458-463
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Labetalol Hydrochloride 5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 160
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Esmolol Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 420
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Allen Loyd V Jr	Nov/Dec 2021 Pg. 504
Procainamide Hydrochloride 100-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 68
Propafenone 1.5-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2008 Pg. 455
Nitazoxanide 20-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2023 Pg. 420
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 183
Return to Top